These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
72 related articles for article (PubMed ID: 14383148)
21. When and how to use heparin prophylaxis and treatment. Turpie AG; Hirsh J Geriatrics; 1979 Jun; 34(6):59-70. PubMed ID: 447077 [TBL] [Abstract][Full Text] [Related]
22. [Clinical value of a new method of therapeutic control of heparin]. Pizzuto J; Garcia S; de la Paz Reyna M; Morales MR; Avilés A; Zavala B; Ponce L; Gaos C Arch Inst Cardiol Mex; 1978; 48(2):373-86. PubMed ID: 666447 [TBL] [Abstract][Full Text] [Related]
23. Inaccuracy of a "spiked curve" for monitoring unfractionated heparin therapy. Gausman JN; Marlar RA Am J Clin Pathol; 2011 Jun; 135(6):870-6. PubMed ID: 21571960 [TBL] [Abstract][Full Text] [Related]
24. Some impressions of the value of heparin in the surgical treatment of peripheral arterial obstruction. LAUBSCHER AE S Afr Med J; 1955 Feb; 29(9):208-10. PubMed ID: 14373078 [No Abstract] [Full Text] [Related]
25. [Percutaneous heparin in inflammatory and trophic disorder of the arm of venous origin]. MILLERET PG Sem Med Prof Med Soc; 1957 Nov; 33(42):1632-3. PubMed ID: 13506642 [No Abstract] [Full Text] [Related]
26. Heparin-polynitroxide derivatives: a platform for new diagnostic and therapeutic agents in cardiovascular disease? Kleschyov AL; Sen' VD Future Med Chem; 2013 Mar; 5(4):385-8. PubMed ID: 23495686 [No Abstract] [Full Text] [Related]
27. [On the therapeutic effect of heparin in hypertension]. GRUNEIS P; VINAZZER H Wien Klin Wochenschr; 1953 Nov; 65(47):960. PubMed ID: 13147141 [No Abstract] [Full Text] [Related]
28. [Action of heparin in the treatment of foveal processes due to atherosclerosis]. STARK H Klin Monbl Augenheilkd Augenarztl Fortbild; 1957; 131(2):165-78. PubMed ID: 13482174 [No Abstract] [Full Text] [Related]
29. [Heparin & pituitary-adrenal hormones in the treatment of tuberculosis]. ALBERT-WEIL J; NEHORAI J Therapie; 1957; 12(3):357-60. PubMed ID: 13455607 [No Abstract] [Full Text] [Related]
31. Development of non-heparin glycosaminoglycans as therapeutic agents. Semin Thromb Hemost; 1991; 17 Suppl 1():1-135. PubMed ID: 2068560 [No Abstract] [Full Text] [Related]
32. Managing the hemorrhagic complications of heparin therapy. Penner JA Hematol Oncol Clin North Am; 1993 Dec; 7(6):1281-9. PubMed ID: 8294317 [TBL] [Abstract][Full Text] [Related]
33. Treatment of chronic weeping eczema with an antibiotic heparin complex. DOLOWITZ DA Eye Ear Nose Throat Mon; 1958 Sep; 37(9):594-6. PubMed ID: 13574197 [No Abstract] [Full Text] [Related]
34. [Heparin (liquemin Roche) in therapy of thrombosis of the axillary vein]. MAYER H Wien Klin Wochenschr; 1957 Aug; 69(31):563-5. PubMed ID: 13468452 [No Abstract] [Full Text] [Related]
35. Heparins in the new millennium: will unfractionated heparin survive? Epilogue. Fareed J; Hoppensteadt DA Semin Thromb Hemost; 2000; 26 Suppl 1():87-8. PubMed ID: 11011812 [No Abstract] [Full Text] [Related]
36. Heparin therapy: current regimens and principles of monitoring. Berry BR; Nantel S Postgrad Med; 1996 Jun; 99(6):64-6, 69-76. PubMed ID: 8668639 [TBL] [Abstract][Full Text] [Related]
37. [Effect of heparin in atherosclerosis; clinical and experimental study]. FRANCO A Med Contemp; 1954 Nov; 72(11):535-51. PubMed ID: 13234993 [No Abstract] [Full Text] [Related]
38. Proposal of a chemotherapy of cancer by hyaluronic acid, chondroitinsulfuric acid, heparin and other polysaccharides containing amino sugars. HUKUSIMA T Gan; 1951 Dec; 42(2-4):144-6. PubMed ID: 14906507 [No Abstract] [Full Text] [Related]
39. [Use of heparin in the prevention of thrombotic complications in aged oncologic patients]. Riabov GA; Pasechnik IN Khirurgiia (Mosk); 1991 Apr; (4):120-3. PubMed ID: 2062046 [TBL] [Abstract][Full Text] [Related]